HIV 1 News and Research

RSS
Research shows effective strategy to target the SARS-CoV-2 spike protein

Research shows effective strategy to target the SARS-CoV-2 spike protein

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Researchers use high-resolution imaging to observe HIV infection process in the cell nucleus

Researchers use high-resolution imaging to observe HIV infection process in the cell nucleus

Are antibody cocktails the key to COVID-19 treatment?

Are antibody cocktails the key to COVID-19 treatment?

HIV: New therapeutic approach to restore the effectiveness of immune cells

HIV: New therapeutic approach to restore the effectiveness of immune cells

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

FDA approves first injectable, complete regimen for HIV-1 infection in adults

FDA approves first injectable, complete regimen for HIV-1 infection in adults

Carbon-based nanomaterials as potential COVID-19 treatments

Carbon-based nanomaterials as potential COVID-19 treatments

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

Research shows that people affected with COVID-19 suffer from cognitive effects

Research shows that people affected with COVID-19 suffer from cognitive effects

Supercomputer simulations lead to an important viral inhibitor discovery

Supercomputer simulations lead to an important viral inhibitor discovery

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

IGC researchers receive three out of six European Research Council grants

IGC researchers receive three out of six European Research Council grants

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

HIV 'wonder drug' may not be as effective as hoped in sub-Saharan Africa, study suggests

Researchers successfully edit SIV virus from genomes of non-human primates

Researchers successfully edit SIV virus from genomes of non-human primates

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

MIT researchers unravel the molecular structure of key coronavirus protein

MIT researchers unravel the molecular structure of key coronavirus protein

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.